Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial.

Brian R Lindman,Federico M Asch,Paul A Grayburn,Michael J Mack,Jeroen J Bax,Holly Gonzales,Kashish Goel,Colin M Barker,Sandip K Zalawadiya,Zhipeng Zhou,Maria C Alu,Neil J Weissman,William T Abraham,JoAnn Lindenfeld,Gregg W Stone

JACC. Cardiovascular interventions（2023）

引用 0|浏览8

暂无评分

摘要

In patients with HF and severe MR, LV reverse remodeling at 6 months was associated with subsequently improved 2-year outcomes but was not affected by TEER or the extent of residual MR. (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation [The COAPT Trial] and COAPT CAS [COAPT]; NCT01626079).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要